Navigation

Augmentin XR

  • Generic Name: amoxicillin clavulanic potassium
  • Brand Name: Augmentin XR
  • Drug Class: Penicillins, Amino

Augmentin XR(Amoxicillin Clavulanic Potassium) side effects drug center

 

PROFESSIONAL

CONSUMER

SIDE EFFECTS

 

Augmentin XR Side Effects Center

What Is Augmentin XR?

Augmentin XR (amoxicillin/clavulante potassium) Extended Release Tablets is a combination of an antibiotic and a B-lactamase inhibitor indicated for patients with community-acquired pneumonia or acute bacterial sinusitis. Augmentin XR is available in generic form.

What Are Side Effects of Augmentin XR?

Side effects of Augmentin XR include:

Dosage for Augmentin XR

The recommended dose of Augmentin XR to treat bacterial sinusitis is 2 tablets every 12 hours, for a duration of 10 days. The recommended dose of Augmentin XR to treat pneumonia is 2 tablets every 12 hours, for 7 to 10 days.

What Drugs, Substances, or Supplements Interact with Augmentin XR?

Augmentin XR may interact with allopurinol, probenecid, blood thinners, or other antibiotics. Tell your doctor all medications and supplements you use.

Augmentin XR During Pregnancy and Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant during treatment with Augmentin XR; it is not expected to be harmful to a fetus. Augmentin XR can make birth control pills less effective. Talk to your doctor about using a non-hormone method of birth control. Augmentin XR can pass into breast milk and may harm a nursing baby. Consult your doctor before breastfeeding.

Additional Information

Our Augmentin XR (amoxicillin/clavulante potassium) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

 

Augmentin XR Consumer Information

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Call your doctor at once if you have:

  • severe stomach pain, diarrhea that is watery or bloody (even if it occurs months after your last dose);
  • pale or yellowed skin, dark colored urine, fever, confusion or weakness;
  • loss of appetite, upper stomach pain;
  • little or no urination; or
  • easy bruising or bleeding.

Common side effects may include:

  • nausea, vomiting; diarrhea;
  • rash, itching;
  • vaginal itching or discharge; or
  • diaper rash.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Augmentin XR (Amoxicillin Clavulanic Potassium)

 

Augmentin XR Professional Information

SIDE EFFECTS

The following are discussed in more detail in other sections of the labeling:

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

In clinical trials, 5,643 patients have been treated with AUGMENTIN XR. The most frequently reported adverse reactions which were suspected or probably drug-related were diarrhea (15%), vaginal mycosis (3%) nausea (2%), and loose stools (2%). AUGMENTIN XR had a higher rate of diarrhea which required corrective therapy (4% versus 3% for AUGMENTIN XR and all comparators, respectively). Two percent of patients discontinued therapy because of drug-related adverse reactions.

Postmarketing Experience

In addition to adverse reactions reported from clinical trials, the following have been identified during postmarketing use of AUGMENTIN products, including AUGMENTIN XR. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to AUGMENTIN.

Gastrointestinal: Diarrhea, nausea, vomiting, indigestion, gastritis, stomatitis, glossitis, black “hairy” tongue, mucocutaneous candidiasis, enterocolitis, and hemorrhagic/pseudo membranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment.

Hypersensitivity Reactions: Skin rashes, pruritus, urticaria, angioedema, serum sickness-like reactions (urticaria or skin rash accompanied by arthritis, arthralgia, myalgia, and frequently fever), erythema multiforme, Stevens-Johnson syndrome, acute generalized exanthematous pustulosis, hypersensitivity vasculitis, and an occasional case of exfoliative dermatitis (including toxic epidermal necrolysis) have been reported [see WARNINGS AND PRECAUTIONS].

Liver: A moderate rise in AST (SGOT) and/or ALT (SGPT) has been noted in patients treated with ampicillin-class antibiotics, but the significance of these findings is unknown. Hepatic dysfunction, including hepatitis and cholestatic jaundice, [see CONTRAINDICATIONS], increases in serum transaminases (AST and/or ALT), serum bilirubin, and/or alkaline phosphatase, has been reported with AUGMENTIN or AUGMENTIN XR. It has been reported more commonly in the elderly, in males, or in patients on prolonged treatment. The histologic findings on liver biopsy have consisted of predominantly cholestatic, hepatocellular, or mixed cholestatic-hepatocellular changes. The onset of signs/symptoms of hepatic dysfunction may occur during or several weeks after therapy has been discontinued. The hepatic dysfunction, which may be severe, is usually reversible. Deaths have been reported [see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].

Renal: Interstitial nephritis, hematuria, and crystalluria have been reported [see OVERDOSAGE].

Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena. There have been reports of increased prothrombin time in patients receiving AUGMENTIN and anticoagulant therapy concomitantly.

Central Nervous System: Agitation, anxiety, behavioral changes, confusion, convulsions, dizziness, headache, insomnia, and reversible hyperactivity have been reported rarely.

Miscellaneous: Tooth discoloration (brown, yellow, or gray staining) has been reported. Most reports occurred in pediatric patients. Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.

Read the entire FDA prescribing information for Augmentin XR (Amoxicillin Clavulanic Potassium)

&Copy; Augmentin XR Patient Information is supplied by Cerner Multum, Inc. and Augmentin XR Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.